6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde

C186H195BBr7N25O20 — CID 157103881

IUPAC6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde
SMILESCC(=O)OCc1c(-c2cc(NC(C)(C)C)c3nccn3c2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(B2OC(C)(C)C(C)(C)O2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(Br)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(C)(C)Nc1cc(-c2cccc(-n3ncc4cc(C(C)(C)C)ccc4c3=O)c2CO)cn2ccnc12.CC(C)(C)Nc1cc(Br)cn2ccnc12.CC(C)(C)c1ccc2c(=O)[nH]ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3C=O)ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3CO)ncc2c1.O=Cc1c(Br)cccc1Br.O=c1[nH]ncc2cc(Br)ccc12
InChIInChI=1S/C32H35N5O3.C30H33N5O2.C27H33BN2O5.C21H21BrN2O3.C19H19BrN2O2.C19H17BrN2O2.C12H14N2O.C11H14BrN3.C8H5BrN2O.C7H4Br2O/c1-20(38)40-19-26-24(22-16-27(35-32(5,6)7)29-33-13-14-36(29)18-22)9-8-10-28(26)37-30(39)25-12-11-23(31(2,3)4)15-21(25)17-34-37;1-29(2,3)21-10-11-23-19(14-21)16-32-35(28(23)37)26-9-7-8-22(24(26)18-36)20-15-25(33-30(4,5)6)27-31-12-13-34(27)17-20;1-17(31)33-16-21-22(28-34-26(5,6)27(7,8)35-28)10-9-11-23(21)30-24(32)20-13-12-19(25(2,3)4)14-18(20)15-29-30;1-13(25)27-12-17-18(22)6-5-7-19(17)24-20(26)16-9-8-15(21(2,3)4)10-14(16)11-23-24;2*1-19(2,3)13-7-8-14-12(9-13)10-21-22(18(14)24)17-6-4-5-16(20)15(17)11-23;1-12(2,3)9-4-5-10-8(6-9)7-13-14-11(10)15;1-11(2,3)14-9-6-8(12)7-15-5-4-13-10(9)15;9-6-1-2-7-5(3-6)4-10-11-8(7)12;8-6-2-1-3-7(9)5(6)4-10/h8-18,35H,19H2,1-7H3;7-17,33,36H,18H2,1-6H3;9-15H,16H2,1-8H3;5-11H,12H2,1-4H3;4-10,23H,11H2,1-3H3;4-11H,1-3H3;4-7H,1-3H3,(H,14,15);4-7,14H,1-3H3;1-4H,(H,11,12);1-4H
InChIKeyAGBPTWYXZXRVTM-UHFFFAOYSA-N
MW3670.90 g/mol
LogP38.96
Rot. Bonds22

About 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde

6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde (PubChem CID 157103881) has the molecular formula C186H195BBr7N25O20 and a molecular weight of 3670.90 g/mol. Its IUPAC name is 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde.

Molecular Properties

Compound Name6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde
PubChem CID157103881
Molecular FormulaC186H195BBr7N25O20
Molecular Weight3670.90 g/mol
Exact Mass3661.94
IUPAC Name6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde
SMILESCC(=O)OCc1c(-c2cc(NC(C)(C)C)c3nccn3c2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(B2OC(C)(C)C(C)(C)O2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(Br)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(C)(C)Nc1cc(-c2cccc(-n3ncc4cc(C(C)(C)C)ccc4c3=O)c2CO)cn2ccnc12.CC(C)(C)Nc1cc(Br)cn2ccnc12.CC(C)(C)c1ccc2c(=O)[nH]ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3C=O)ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3CO)ncc2c1.O=Cc1c(Br)cccc1Br.O=c1[nH]ncc2cc(Br)ccc12
InChIInChI=1S/C32H35N5O3.C30H33N5O2.C27H33BN2O5.C21H21BrN2O3.C19H19BrN2O2.C19H17BrN2O2.C12H14N2O.C11H14BrN3.C8H5BrN2O.C7H4Br2O/c1-20(38)40-19-26-24(22-16-27(35-32(5,6)7)29-33-13-14-36(29)18-22)9-8-10-28(26)37-30(39)25-12-11-23(31(2,3)4)15-21(25)17-34-37;1-29(2,3)21-10-11-23-19(14-21)16-32-35(28(23)37)26-9-7-8-22(24(26)18-36)20-15-25(33-30(4,5)6)27-31-12-13-34(27)17-20;1-17(31)33-16-21-22(28-34-26(5,6)27(7,8)35-28)10-9-11-23(21)30-24(32)20-13-12-19(25(2,3)4)14-18(20)15-29-30;1-13(25)27-12-17-18(22)6-5-7-19(17)24-20(26)16-9-8-15(21(2,3)4)10-14(16)11-23-24;2*1-19(2,3)13-7-8-14-12(9-13)10-21-22(18(14)24)17-6-4-5-16(20)15(17)11-23;1-12(2,3)9-4-5-10-8(6-9)7-13-14-11(10)15;1-11(2,3)14-9-6-8(12)7-15-5-4-13-10(9)15;9-6-1-2-7-5(3-6)4-10-11-8(7)12;8-6-2-1-3-7(9)5(6)4-10/h8-18,35H,19H2,1-7H3;7-17,33,36H,18H2,1-6H3;9-15H,16H2,1-8H3;5-11H,12H2,1-4H3;4-10,23H,11H2,1-3H3;4-11H,1-3H3;4-7H,1-3H3,(H,14,15);4-7,14H,1-3H3;1-4H,(H,11,12);1-4H
InChIKeyAGBPTWYXZXRVTM-UHFFFAOYSA-N
XLogP38.96
TPSA560.79 Ų
H-Bond Donors7
H-Bond Acceptors43
Rotatable Bonds22
Heavy Atoms239
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003670.90
LogP ≤ 538.96
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydroisoquinolin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydroisoquinolin-2-yl)phenyl]methyl acetate;6-bromo-3,4-dihydro-2H-isoquinolin-1-one;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butyl-3,4-dihydroisoquinolin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxo-3,4-dihydroisoquinolin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]-3,4-dihydroisoquinolin-1-one;6-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;[2-(6-tert-butyl-1-oxo-3,4-dihydroisoquinolin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;2,6-dibromobenzaldehyde
CID 157957070
6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxoisoquinolin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxoisoquinolin-2-yl)phenyl]methyl acetate;6-bromo-3,4-dihydro-2H-isoquinolin-1-one;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylisoquinolin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxoisoquinolin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]isoquinolin-1-one;6-tert-butyl-2H-isoquinolin-1-one;[2-(6-tert-butyl-1-oxoisoquinolin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;2,6-dibromobenzaldehyde
CID 158263338
[2-bromo-6-(7-tert-butyl-4-oxo-1H-quinolin-3-yl)phenyl]methyl acetate;7-bromo-1H-quinolin-4-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(7-tert-butyl-4-oxo-1H-quinolin-3-yl)phenyl]methyl acetate;7-tert-butyl-3-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]-1H-quinolin-4-one;7-tert-butyl-1H-quinolin-4-one;N-tert-butyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyrazin-8-amine;(2,6-dibromophenyl)methyl acetate
CID 158326006
[4-[6-[[6-[2-(Acetyloxymethyl)-3-(6-tert-butyl-8-fluoro-1-oxophthalazin-2-yl)phenyl]imidazo[1,2-a]pyridin-8-yl]amino]-3-pyridinyl]piperidin-1-yl]-methylborinic acid;[4-[6-[(6-bromoimidazo[1,2-a]pyridin-8-yl)amino]-3-pyridinyl]piperidin-1-yl]-methylborinic acid;[2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate
CID 158759987
(6-Amino-3-pyridinyl)-morpholin-4-ylmethanone;8-bromo-6-iodo-[1,2,4]triazolo[1,5-a]pyridine;[2-(8-bromo-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-6-(6-tert-butyl-8-fluoro-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-8-fluoro-2-[2-(hydroxymethyl)-3-[8-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]phthalazin-1-one;[2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2-yl)-6-[8-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]methyl acetate;[2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate
CID 159228499
[4-[(6-Bromoimidazo[1,2-a]pyridin-8-yl)amino]phenyl]-morpholin-4-ylmethanone;5-bromo-3-iodopyridin-2-amine;6-tert-butyl-8-fluoro-2-[2-(hydroxymethyl)-3-[8-[4-(morpholine-4-carbonyl)anilino]imidazo[1,2-a]pyridin-6-yl]phenyl]phthalazin-1-one;[2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2-yl)-6-[8-[4-(morpholine-4-carbonyl)anilino]imidazo[1,2-a]pyridin-6-yl]phenyl]methyl acetate;6,8-dibromoimidazo[1,2-a]pyridine
CID 160115360
6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydroisoquinolin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydroisoquinolin-2-yl)phenyl]methyl acetate;6-bromo-3,4-dihydro-2H-isoquinolin-1-one;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butyl-3,4-dihydroisoquinolin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxo-3,4-dihydroisoquinolin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]-3,4-dihydroisoquinolin-1-one;6-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;[2-(6-tert-butyl-1-oxo-3,4-dihydroisoquinolin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;2,6-dibromobenzaldehyde
CID 160345639
6-bromo-N-tert-butylimidazo[1,2-a]pyrazin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyrazin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde
CID 160765093
[2-bromo-6-(7-tert-butyl-4-oxo-1H-quinolin-3-yl)phenyl]methyl acetate;7-bromo-1H-quinolin-4-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(7-tert-butyl-4-oxo-1H-quinolin-3-yl)phenyl]methyl acetate;7-tert-butyl-3-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]-1H-quinolin-4-one;7-tert-butyl-1H-quinolin-4-one;N-tert-butyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-8-amine;(2,6-dibromophenyl)methyl acetate
CID 160897929
[4-[(6-Bromoimidazo[1,2-a]pyridin-8-yl)amino]phenyl]-morpholin-4-ylmethanone;[2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2-yl)-6-[8-[4-(morpholine-4-carbonyl)anilino]imidazo[1,2-a]pyridin-6-yl]phenyl]methyl acetate;[2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate
CID 161999972

Frequently Asked Questions

What is the IUPAC name of 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde?
The IUPAC name of 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde (CID 157103881) is 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde.
What is the SMILES notation for 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde?
The canonical SMILES for 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde is CC(=O)OCc1c(-c2cc(NC(C)(C)C)c3nccn3c2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(B2OC(C)(C)C(C)(C)O2)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(=O)OCc1c(Br)cccc1-n1ncc2cc(C(C)(C)C)ccc2c1=O.CC(C)(C)Nc1cc(-c2cccc(-n3ncc4cc(C(C)(C)C)ccc4c3=O)c2CO)cn2ccnc12.CC(C)(C)Nc1cc(Br)cn2ccnc12.CC(C)(C)c1ccc2c(=O)[nH]ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3C=O)ncc2c1.CC(C)(C)c1ccc2c(=O)n(-c3cccc(Br)c3CO)ncc2c1.O=Cc1c(Br)cccc1Br.O=c1[nH]ncc2cc(Br)ccc12.
What is the InChIKey of 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde?
The InChIKey is AGBPTWYXZXRVTM-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H35N5O3.C30H33N5O2.C27H33BN2O5.C21H21BrN2O3.C19H19BrN2O2.C19H17BrN2O2.C12H14N2O.C11H14BrN3.C8H5BrN2O.C7H4Br2O/c1-20(38)40-19-26-24(22-16-27(35-32(5,6)7)29-33-13-14-36(29)18-22)9-8-10-28(26)37-30(39)25-12-11-23(31(2,3)4)15-21(25)17-34-37;1-29(2,3)21-10-11-23-19(14-21)16-32-35(28(23)37)26-9-7-8-22(24(26)18-36)20-15-25(33-30(4,5)6)27-31-12-13-34(27)17-20;1-17(31)33-16-21-22(28-34-26(5,6)27(7,8)35-28)10-9-11-23(21)30-24(32)20-13-12-19(25(2,3)4)14-18(20)15-29-30;1-13(25)27-12-17-18(22)6-5-7-19(17)24-20(26)16-9-8-15(21(2,3)4)10-14(16)11-23-24;2*1-19(2,3)13-7-8-14-12(9-13)10-21-22(18(14)24)17-6-4-5-16(20)15(17)11-23;1-12(2,3)9-4-5-10-8(6-9)7-13-14-11(10)15;1-11(2,3)14-9-6-8(12)7-15-5-4-13-10(9)15;9-6-1-2-7-5(3-6)4-10-11-8(7)12;8-6-2-1-3-7(9)5(6)4-10/h8-18,35H,19H2,1-7H3;7-17,33,36H,18H2,1-6H3;9-15H,16H2,1-8H3;5-11H,12H2,1-4H3;4-10,23H,11H2,1-3H3;4-11H,1-3H3;4-7H,1-3H3,(H,14,15);4-7,14H,1-3H3;1-4H,(H,11,12);1-4H.
What are the key properties of 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde?
6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde has a molecular weight of 3670.90 g/mol, XLogP of 38.96, 22 rotatable bonds, 7 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-N-tert-butylimidazo[1,2-a]pyridin-8-amine;2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)benzaldehyde;[2-bromo-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;2-[3-bromo-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one;6-bromo-2H-phthalazin-1-one;[2-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-6-(6-tert-butyl-1-oxophthalazin-2-yl)phenyl]methyl acetate;6-tert-butyl-2-[3-[8-(tert-butylamino)imidazo[1,2-a]pyridin-6-yl]-2-(hydroxymethyl)phenyl]phthalazin-1-one;[2-(6-tert-butyl-1-oxophthalazin-2-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl acetate;6-tert-butyl-2H-phthalazin-1-one;2,6-dibromobenzaldehyde is sourced from PubChem (CID 157103881), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).